CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Cotinga Pharmaceuticals Inc Company Snapshot
Cotinga Pharmaceuticals Inc operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Cotinga Pharmaceuticals Inc with three other companies in this sector in Canada: Abattis Bioceuticals Corp (2013 sales of 17,448.00 Canadian Dollars [US$14,025.75 ] ), Novoheart Holdings Inc (11,560.00 Canadian Dollars [US$9,292.62 ] ), and Promis Neurosciences Inc (49,516.00 Canadian Dollars [US$39,803.93 ] of which 100% was Research and Development).

Sales Analysis.
   
   
 
  Stock Performance Chart for Cotinga Pharmaceuticals Inc
 
  Stock Data: Recent Stock Performance:
  Current Price (1/19/2018): .87
(Figures in Canadian Dollars)
1 Week -17.1%   13 Weeks -24.3%  
4 Weeks -24.3%   52 Weeks -82.4%  
 
Cotinga Pharmaceuticals Inc Key Data:
  Ticker: COT Country: Canada
  Exchanges: VEN Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2013 Sales 30,588
(Year Ending Jan 2014).
Employees: 10
  Currency: Canadian Dollars Market Cap: 14,517,662
  Fiscal Yr Ends: April Shares Outstanding: 16,686,968
  Share Type: Closely Held Shares: 1,920,717
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.